TH7976A - Better infection-prevention mixtures containing hexahydro-5-pyrimidinamine and thymol compounds, and methods for preparing this mixtures. - Google Patents
Better infection-prevention mixtures containing hexahydro-5-pyrimidinamine and thymol compounds, and methods for preparing this mixtures.Info
- Publication number
- TH7976A TH7976A TH8901001182A TH8901001182A TH7976A TH 7976 A TH7976 A TH 7976A TH 8901001182 A TH8901001182 A TH 8901001182A TH 8901001182 A TH8901001182 A TH 8901001182A TH 7976 A TH7976 A TH 7976A
- Authority
- TH
- Thailand
- Prior art keywords
- mixtures
- infection
- products
- methods
- preparing
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract 9
- 239000000203 mixture Substances 0.000 title claims abstract 8
- BKXBSQULLDQCLC-UHFFFAOYSA-N 1,3-diazinan-5-amine Chemical compound NC1CNCNC1 BKXBSQULLDQCLC-UHFFFAOYSA-N 0.000 title abstract 2
- 125000003639 thymyl group Chemical class C1(=CC(C)=CC=C1C(C)C)* 0.000 title 1
- 235000009508 confectionery Nutrition 0.000 claims abstract 6
- 239000004615 ingredient Substances 0.000 claims abstract 5
- 239000000126 substance Substances 0.000 claims abstract 4
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000012678 infectious agent Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 abstract 2
- 206010048685 Oral infection Diseases 0.000 abstract 1
- 239000005844 Thymol Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960000790 thymol Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Abstract
การประดิษฐ์นี้เกี่ยวกับสารผสมที่ใช้ป้องกันการติดเชื้อในปากซึ่งประกอบด้วยตัวอย่างเช่น สารผสมที่เสริมฤทธิ์ป้องกัน การติดเชื้อในปริมาณที่มีผลในการรักษา ซึ่งประกอบด้วยสาร ประกอบเฮกซะไฮโดร-5-พิริมิดิแนมีนที่ใช้ป้องกันการติดเชื้อ และไธมอลในสารทำที่ใช้ทางปากหรือในพาหะที่ยอมรับทางเภสัชศาสตร์ เช่นสารผสมส่วนใหญ่ที่เป็นสารผสมรสหวาน สารผสมที่เสริมฤทธิ์ ป้องกันการติดเชื้อนี้อาจจะใช้ประโยชน์ได้ในผลิตภัณฑ์ที่ ป้องกันการติดเชื้อในปากซึ่งมีน้ำเป็นพื้นฐานและผลิตภัณฑ์ สารผสมรสหวานชนิดต่าง ๆ มากมาย การประดิษฐ์นี้เกี่ยวข้องกับ วิธีซึ่งอาจจะใช้เตรียมผลิตภัณฑ์ที่ใช้ป้องกันการติดเชื้อใน ปากและผลิตภัณฑ์สารผสมรสหวานเหล่านี้อีกด้วยเหมือนกัน สิทธิบัตรยา The invention involves mixtures used to prevent oral infections including, for example: Mixture that enhances the protective effect Infection in the amount that has a therapeutic effect Containing substances Contains hexahydro-5-pyrimidinamines used to prevent infection. And thymol in substances used by mouth or in pharmacologically acceptable carriers Like most mixtures that are sweet ingredients Synergistic mixtures Preventing this infection may be useful in products that Prevent infection in the water-based mouth and products Many different types of sweet ingredients. This invention relates to A method, which may be used to prepare products used to prevent infection in These oral and sweet ingredient products are also patented.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH7976A true TH7976A (en) | 1990-08-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE113604T1 (en) | MOMETASONE FUROATE MONOHYDRATE, PROCESS FOR ITS PREPARATION AND THE CONTAINING PHARMACEUTICAL COMPOSITIONS. | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| TW366286B (en) | Flavour-masked pharmaceutical compositions | |
| CA2427227A1 (en) | Lactam compound | |
| IT1241996B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION. | |
| PT97638A (en) | METHOD FOR THE PREPARATION OF PEPTIDICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
| DE69213010D1 (en) | Use of a bacteriocin antibiotic agent in the manufacture of a medicament for the treatment of upset stomach caused by Helicobacter pylori. | |
| KR880011197A (en) | Compositions and Methods for Treating Gastrointestinal Disorders | |
| EP0373758A3 (en) | Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and a process for their preparation | |
| IL94819A0 (en) | 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| CA2173147A1 (en) | Anti-obesity agent | |
| KR930005619A (en) | Drugs for treating gastrointestinal diseases | |
| DE60002126D1 (en) | Substituted dimeric carboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| CA2157792A1 (en) | N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists | |
| RU93053905A (en) | OXYPURINE NUCLEOSIDES AND RELATED COMPOUNDS THEREOF, AND ALSO THEIR Acyl DERIVATIVES TO IMPROVE HEMOPOESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT AND / OR PREVENTION | |
| EG19302A (en) | Compound with gastric acid inhibitory effect and process for its preparation | |
| DE3887068D1 (en) | 2,2-Dimethylchromene derivatives, process for their preparation and pharmaceutical compositions containing them. | |
| HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| HUT47124A (en) | Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients | |
| TH7976A (en) | Better infection-prevention mixtures containing hexahydro-5-pyrimidinamine and thymol compounds, and methods for preparing this mixtures. | |
| HU9400405D0 (en) | Pharmaceutical compositions containing carbachol and other cholinergic substances | |
| HUT46364A (en) | Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient | |
| IT1228437B (en) | "DERIVATIVES OF 2,3,4,5,6,7 HEXAIDRO 2,7-METHANE-1,5 BENZOXAZONINE (RESPECTIVELY 1,4 BENZOXAZONINE), PROCEDURE FOR THEIR PREPARATION AND MEDICINAL PRODUCTS THAT CONTAIN THESE COMPOUNDS. |